Comparison of nonionic contrast agents iohexol and iotrolan for cisternal myelography in dogs.
During this investigation, the use of iohexol was compared with iotrolan for canine cisternal myelography. Iohexol and iotrolan myelography was done in 6 dogs by cisternal puncture with a 6-week interval between both procedures; each dog served as its own control. Cerebrospinal fluid (CSF) was collected for baseline analysis from each dog immediately before the contrast agent was injected. Cerebrospinal fluid samples were obtained at 1, 3, 7, and 14 days after injection of each contrast medium for cytologic and chemical analysis. Total CSF leucocyte count and glucose concentration did not change significantly in comparison with baseline data in any of the samples. After the injection of iohexol, protein concentration increased significantly in the 24-hour sample, and lactate dehydrogenase activity increased significantly in the 3-day sample. Significant difference was not found between the different samples collected at 1, 3, 7, and 14 days, compared with both contrast media. None of the dogs had seizure activity during a 5-hour postmyelographic observation period. Pathologic changes were not found by gross or microscopic examination of the spinal cord. Although a degradation in time of radiographic quality of all myelograms took place, the average radiographic score decreased more rapidly with iohexol. The average score at 90 minutes with iotrolan was comparable with the score at 45 minutes with iohexol, and the average score at 150 minutes with iotrolan was better than the score at 90 minutes with iohexol. At 5 and 10 minutes after cisternal injection, no significant difference was observable between the myelograms, but from 45 minutes onward, myelograms with iotrolan were superior.
van Bree
H
H
Small Animal Clinic, State University of Ghent, Belgium.
Van Rijssen
B
B
Van Ham
L
L
D000818:Animals; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D003287:Contrast Media; D004285:Dogs / Q000134:cerebrospinal fluid; D005260:Female; D005947:Glucose / Q000134:cerebrospinal fluid; D007472:Iohexol / Q000009:adverse effects; D007770:L-Lactate Dehydrogenase / Q000134:cerebrospinal fluid; D007958:Leukocyte Count / Q000662:veterinary; D008297:Male; D009192:Myelography / Q000379:methods / Q000592:standards / Q000662:veterinary*; D013046:Specific Gravity; D014283:Triiodobenzoic Acids / Q000009:adverse effects
D002556:Cerebrospinal Fluid Proteins; D003287:Contrast Media; D014283:Triiodobenzoic Acids; C033300:iotrolan; D007472:Iohexol; D007770:L-Lactate Dehydrogenase; D005947:Glucose